fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Psych drugs increase in care homes

Written by | 21 Feb 2013

A study by Queen’s University Belfast has found that the dispensing of psychotropic drugs to older people in Northern Ireland increases on entry to care homes.  According to… read more.

Hypertension – Treat to target with multiple agents

Written by | 20 Feb 2013

by Christine Clark FRPharmS – In association with A.Menarini Pharmaceuticals Ireland Ltd. and Daiichi Sankyo Pharmaceuticals Ireland Ltd. 

Radio waves lower persistent high blood pressure

Written by | 20 Feb 2013

Directing short bursts of radio waves at nerves surrounding the kidneys lowered blood pressure for at least six months and up to one year among patients with hypertension… read more.

Mis-folded proteins in heart cells are a key factor in the process of heart failure

Written by | 20 Feb 2013

Despite a substantial increase in the number of people suffering the debilitating and often deadly effects of heart failure, treatments for the condition have not advanced significantly for… read more.

Beta-blockers – versatile and effective

Written by | 19 Feb 2013

In association with A.Menarini Pharmaceuticals Ireland Ltd – Beta-blockers are one of the most valuable classes of drugs in the therapeutic armamentarium. They have an established place in… read more.

Amoxicillin appears to be ineffective for cough

Written by | 12 Feb 2013

Taken from The Lancet – by Bruce Sylvester – Patients with cough treated with amoxicillin do not recover significantly more quickly or have significantly fewer symptoms than other… read more.

Drug companies facing higher fees

Written by | 8 Feb 2013

EMA Highlights by Gary Finnegan – Pharmaceutical companies will have to pay more to have their new medicines evaluated, if the European Medicines Agency is to balance its… read more.

Green light for new medicines

Written by | 8 Feb 2013

EMA Highlights by Gary Finnegan – Several new medicines have been approved by the EMA’s influential Committee for Medicinal Products for Human Use (CHMP), including the first non-surgical… read more.

Combination antiretroviral therapy lowers risk of malaria recurrence in Pediatric HIV

Written by | 7 Feb 2013

FDA Highlights by Bruce Sylvester – Combination antiretroviral therapy significantly reduces the risk of recurrent malaria among HIV-positive children,

Meditation technique appears to cut mortality, heart attack and stroke among heart disease patients

Written by | 5 Feb 2013

Patients with heart disease who practiced transcendental meditation regularly over a 5-year period were 48 percent less likely to have a heart attack, stroke or die from all… read more.

Stem-cell approach shows promise for Duchenne muscular dystrophy

Written by | 28 Jan 2013

http://www.eurekalert.org/multimedia/pub/51742.php?from=230078 Researchers have shown that transplanting stem cells derived from normal mouse blood vessels into the hearts of mice that model the pathology associated with Duchenne muscular dystrophy… read more.

Immune cells engineered in lab to resist HIV infection, Stanford study shows

Written by | 24 Jan 2013

Researchers at the Stanford University School of Medicine have found a novel way to engineer key cells of the immune system so they remain resistant to infection with… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.